Patient‐focused outcomes following detection in a hospital‐based screening programme for C282Y haemochromatosis

Abstract

The proportion of detected subjects who commenced venesection was significant. Results suggest that clinical penetrance is higher in Australia than other countries and that even in the environment of a large tertiary teaching hospital, phenotypic screening identifies cases of hereditary haemochromatosis, which are likely to benefit from treatment.